Comparative evaluation of Biofire Joint Infection Panel, Sepsitest 16S/18S rDNA PCR, and culture to identify microorganisms in explanted heart valves
Open Access
- 2 September 2025
- journal article
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (9) , e0126325
Abstract
Infective endocarditis (IE) is a major life-threatening disease. However, the inability to identify the causative pathogen using conventional microbiological cultures jeopardizes the choice of optimal antibiotic therapy. Culture-independent molecular techniques for pathogen detection may overcome this challenge. Here, two molecular tests (16S/18S rDNA assay [SepsiTest, Molzym, Germany]; Biofire Joint Infection Panel [BJP, bioMérieux, Marcy l’Étoile, France]) were analyzed for their ability to detect pathogens in a series of 100 explanted heart valves. In total, at least one pathogen was detected in 67/100 specimens by one or more methods, and 33/100 specimens were negative in all three assays. Overall, valve-culture had an inferior sensitivity (39.4%), compared to 16S/18S rDNA PCR (90.9%) and the BJP (83.1% [all organisms], 98.2% [on-panel organisms only]). In culture-negative cases, 35 and 32 additional pathogens were identified by 16S/18S rDNA PCR and BJP, respectively. In five culture- and 16S/18S rDNA assay-negative cases, BJP identified correctly additional pathogens. False-positive results were observed in one (16S/18S rDNA PCR) and two (BJP) cases, respectively. In conclusion, both culture-independent assays proved to be reliable and increased the diagnostic yield compared to culture. In general, false negatives (i.e., off-panel pathogens in BJP) and false positives require careful clinical evaluation of results from culture-independent techniques. Diagnostic stewardship is essential to guide the optimal use of molecular techniques in the work-up of infective endocarditis. IMPORTANCE: Infective endocarditis (IE) therapy must be guided by the identification of the causative pathogen. Microbiological cultures, however, remain negative in a significant number of cases, jeopardizing the choice of optimal anti-infective treatment. This study evaluated the ability of two independent molecular tests (16/18S rDNA PCR, syndromic panel PCR [Biofire JI panel]) to overcome limitations of conventional microbiological approaches to detect microorganisms from explanted heart valve tissues. Both assays proved to have a greater sensitivity compared to conventional culture, and PCR and BJP identified a pathogen in 35 and 32 out of 74 culture negative IE cases, additional pathogens, respectively. The study highlights the great importance of culture-independent approaches to pathogen detection in IE and guides the choice of the optimal assay using diagnostic stewardship interventions.Keywords
This publication has 26 references indexed in Scilit:
- 2023 ESC Guidelines for the management of endocarditisEuropean Heart Journal, 2023
- The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke CriteriaClinical Infectious Diseases, 2023
- The added value of a commercial 16S/18S-PCR assay (UMD-SelectNA, Molzym) for microbiological diagnosis of spondylodiscitis: an observational studyDiagnostic Microbiology and Infectious Disease, 2023
- A multicentre evaluation and expert recommendations of use of the newly developed BioFire Joint Infection polymerase chain reaction panelEuropean Journal of Clinical Microbiology & Infectious Diseases, 2022
- 16S rDNA PCR for the aetiological diagnosis of culture-negative infective endocarditisInfection, 2021
- Clinical metagenomicsNature Reviews Genetics, 2019
- Clinical Outcomes of Infective Endocarditis in Injection Drug UsersJACC, 2019
- Heart Valve Culture and Sequencing to Identify the Infective Endocarditis Pathogen in Surgically Treated PatientsThe Annals of Thoracic Surgery, 2015
- Comprehensive Diagnostic Strategy for Blood Culture–Negative Endocarditis: A Prospective Study of 819 New CasesClinical Infectious Diseases, 2010
- Infective endocarditisThe Lancet, 2004